ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,431, issued on Sept. 9, was assigned to Ospedale Pediatrico Bambino Gesu' (Rome).

"Short interfering RNA targeting variant C1858T of gene PTPN22" was invented by Alessandra Fierabracci (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns a short Interfering RNA, which is variant C1858T PTPN22 short interfering RNA duplexes (siRNA), and uses thereof in medical field in the prevention and treatment of autoimmune diseases."

The patent was filed on May 8, 2019, under Application No. 17/053,816.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...